(o) Provisions
Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. When the Company expects some or all of a provision to be reimbursed, the reimbursement is recognised as a separate asset but only when the reimbursement is virtually certain. The expense relating to any provision is presented in the standalone statement of profit and loss net of any reimbursement.
If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects, when appropriate, the risks specific to the liability. When discounting is used, the increase in the provision due to the passage of time is recognised as a finance cost.
Provisions are reviewed at the end of each reporting period and adjusted to reflect the current best estimate. If it is no longer probable that an outflow of resources would be required to settle the obligation, the provision is reversed.
(p) Contingent assets/liabilities
Contingent liabilities are possible obligations that arise from past events and whose existence will only be confirmed by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the Company.
Where it is not probable that an outflow of economic benefits will be required, or the amount cannot be estimated reliably, the obligation is disclosed as a contingent liability, unless the probability of outflow of economic benefits is remote.
Contingent assets are not recognised. However, when realization of income is virtually certain, then the related asset is no longer a contingent asset, and is recognised as an asset.
(q) Income taxes
Income tax expense comprises of current tax and deferred tax. It is recognised in the profit or loss except to the extent that it relates to items recognised in other comprehensive income or directly in equity.
Current tax
Current tax comprises the expected tax payable or receivable on the taxable income or loss for the year and any adjustment to the tax payable or receivable in respect of previous years. The amount of current tax reflects the best estimate of the tax amount expected to be paid or received after considering the uncertainty, if any relating to income taxes. It is measured using tax rates enacted for the relevant reporting period.
Current tax assets and current tax liabilities are offset only if there is a legally enforceable right to set off the recognised amounts, and it is intended to realise the asset and settle the liability on a net basis.
Deferred tax
Deferred tax is recognised in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the corresponding amounts used for taxation purposes. Deferred tax is also recognised in respect of carried forward losses and tax credits. Deferred tax is not recognised for temporary differences arising on the initial recognition of assets or liabilities in a transaction that is not a business combination and that effects neither accounting not taxable profit or loss at the time of the transaction.
Deferred tax liabilities are recognised for all taxable temporary differences. Deferred tax assets are recognised to the extent that it is probable that future taxable profits will be available against which they can be used. The existence of unused tax losses is strong evidence that future taxable profit may not be available. Therefore, in case of a history of recent losses, the Company recognises a deferred tax asset only to the extent that it has sufficient taxable temporary differences or there is convincing other evidence that sufficient taxable profit will be available against which such deferred tax asset can be realised. Deferred tax assets - unrecognised or recognised, are reviewed at each reporting date and are recognised/ reduced to the extent that it is probable/no longer probable respectively that the related tax benefit will be realised.
Deferred tax is measured at the tax rates that are expected to apply to the period when the asset is realised or liability is settled, based on the laws that have been enacted or substantively enacted by the reporting date.
The measurement of deferred tax reflects the tax consequences that would follow from the manner in which the Company expects, at the reporting date, to recover or settle the carrying amount of its assets and liabilities.
Deferred tax assets and deferred tax liabilities are offset only if there is a legally enforceable right to offset current tax liabilities and assets levied by the same tax authorities.
(r) Earnings per share
The Company presents basic and diluted earnings per share (EPS) data for its equity shares. Basic EPS is calculated by dividing the standalone Statement of profit and loss attributable to equity shareholders of the Company by the weighted average number of equity shares outstanding during the year. Diluted EPS is determined by adjusting standalone Statement of profit and loss attributable to equity shareholders and the weighted average number of equity shares outstanding, for the effects of all dilutive potential equity shares, which comprise share options granted to employees.
The number of equity shares and potentially dilutive equity shares are adjusted retrospectively for all periods presented for any share splits and bonus shares issues including for changes effected prior to the approval of the standalone financial statements by the Board of Directors.
(s) Cash and cash equivalents
Cash and cash equivalents in the balance sheet comprise cash at banks and on hand and short-term deposits with an original maturity of three months or less, which are subject to an insignificant risk of changes in value.
For the purpose of the standalone statement of cash flows, cash and cash equivalents consist of cash and short-term deposits, as defined above.
(t) Segment reporting
An operating segment is a component of the Company that engages in business activities from which it may earn revenues and incur expenses, including revenues and expenses that relate to transactions with any of the Company's other components, and for which discrete financial information is available. All operating segments' operating results are regularly reviewed by the Company's chief operating decision maker to make decisions about resources to be allocated to the segments and assess their performance. The Company's chief executive officer is the chief operating decision maker.
(u) Impairment of non-financial assets
The company assesses at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment testing for an asset is required, the company estimates the asset's recoverable amount. An asset's recoverable amount is the higher of an asset's or cash-generating unit's (CGU) fair value less costs of disposal and its value in use. Recoverable amount is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups of assets.
Impairment loss is recognised when the carrying amount of an asset exceeds recoverable amount and the asset is written down to its recoverable amount.
In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset. In determining fair value less costs of disposal, recent market transactions are taken into account. If no such transactions can be identified, an appropriate valuation model is used.
Company bases its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years. For longer periods, a long-term growth rate is calculated and applied to project future cash flows after the fifth year.
To estimate cash flow projections beyond periods covered by the most recent budgets/forecasts, company extrapolates cash flow projections in the budget using a steady or declining growth rate for subsequent years, unless an increasing rate can be justified. In any case, this growth rate does not exceed the long-term average growth rate for the products, industries, or country or countries in which the entity operates, or for the market in which the asset is used.
For assets excluding goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognised impairment losses no longer exist or have decreased. If such indication exists, the Company estimates the asset's or CGU's recoverable amount. A previously recognised impairment loss is reversed only if there has been a change in the assumptions used to determine the asset's recoverable amount since the last impairment loss was recognised. The reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognised for the asset in prior years. Such reversal is recognised in the standalone statement of profit and loss unless the asset is carried at a revalued amount, in which case, the reversal is treated as a revaluation increase.
(v) Inventories
Inventories are valued at the lower of cost and net realizable value in accordance with the provisions of IND AS 2.
Inventories comprise medicines, healthcare products, and consumables used in providing Panchkarma and other therapies/treatment services, as well as goods held for sale.
Inventories are valued at the lower of cost and net realisable value, in accordance with Ind AS 2. Cost includes purchase price, duties and taxes (net of recoverable taxes), freight, and other costs incurred in bringing the inventories to their present location and condition. Cost is determined using the First-In-First-Out method.
Medicines and other items held for sale are recognised as inventory and expensed to cost of goods sold upon sale.
Consumables used in rendering panchkarma, and related services are recognised as expenses in the period in which such services are provided, based on actual consumption.
Net realisable value is estimated based on the expected selling price in the ordinary course of business, less estimated costs necessary to make the sale. The Company evaluates inventories at each reporting date for obsolescence, expiry, and slow-moving items, particularly for medicines with limited shelf life, and provides for diminution in value, where necessary.
(w) Events occurring after the Balance Sheet date
Impact of events occurring after the balance sheet date that provide additional information materially effecting the determination of the amounts relating to conditions existing at the balance sheet date are adjusted to respective assets and liabilities.
(x) New and amended standards adopted by the Company
The Company applied for the first-time certain standards and amendments, which are effective for annual periods beginning on or after 1 April 2025. The Company has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.
The Ministry of Corporate Affairs ("MCA") notifies amendments to Indian Accounting Standards ('lnd AS') from time to time under Section 133 of the Companies Act, 2013, read with the Companies (Indian Accounting Standards) Rules, 2015.
Standards and amendments effective for the year ended 31 March 2026 The following amendments became effective for annual reporting periods beginning on or after 1 April 2025 and have been applied by the Company where relevant.
Amendments to lnd AS 21 - The Effects of Changes in Foreign Exchange Rates
The amendments prescribe accounting and disclosure requirements in situations where a currency is not exchangeable, including guidance on estimating the spot exchange rate when exchangeability is lacking and related disclosures.
Amendments to lnd AS 1 - Presentation of Financial Statements
These amendments clarify the principles for classification of liabilities as current or non-current, particularly in relation to the assessment of the right to defer settlement and the impact of covenants.
Amendments to lnd AS 12 - lncome Taxes
The amendments introduce a temporary exception from the recognition of deferred tax assets and liabilities arising from the OECD's Pillar Two global minimum tax regime and prescribe additional disclosures relating to exposure to such taxes.
Amendments to lnd AS 7 - Statement of Cash Flows and lnd AS 107 - Financial lnstruments: Disclosures
These amendments introduce enhanced disclosure requirements for supplier finance arrangements.
lnd AS 19 - Employee Benefits and Labour Codes
During the year, the Government of lndia implemented the Code on Wages, 2019; the Code on Social Security, 2020; The Industrial Relations Code, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 with effect from 2l November 2025.
The Company has evaluated the impact of the above amendments and concluded that they do not have any material impact on the Company's financial statements for the year ended 31 March 2026, considering the nature and extent of the Company's operations.
Standards issued but not yet effective lnd AS 1 - Presentation of Financial Statements.
lf covenant breach occurs on or before the reporting date and the liability becomes payable on demand, it must be classified as current, even if the lender subsequently agrees not to demand repayment. lt is classified as current because, at the reporting date, the entity does not have the right to defer settlement for at least 12 months. However, if the lender has already provided by the reporting date, a grace period extending at least 12 months beyond that date, during which the breach can be rectified and repayment cannot be demanded, the liability is classified as non¬ current. This amendment is to be applied retrospectively for annual reporting periods beginning on or after 1 April 2026, in accordance with lnd AS 8, Accounting Policies, Changes in Accounting Estimates and Errors.
Note - Impairment tests for goodwill:
The Company tests cash-generating units with goodwill annually for impairment, or more frequently if there is an indication that a cash-generating unit to which goodwill has been allocated may be impaired. The recoverable amount of a cash generating unit is the higher of the cash-generating unit's fair value less cost of disposal ('FVLCD') and its value-in-use.
For the purpose of annual impairment testing, goodwill is allocated to the operating segments expected to benefit from the synergies of the business combinations in which the goodwill arises as set out below, and is compared to its recoverable value:
Calculation of the value-in-use is based on cash flow projections on reasonable and supportable assumptions that represent economic conditions that will exist over the remaining useful life of the assets, approved by the management, but shall exclude any estimated future cash inflows or outflows expected to arise from future restructurings or from improving or enhancing asset performance.
As at 31 March 2026, the Company held goodwill of 5 5,811.82 lakhs attributable to identified Cash Generating Units (CGUs) resulting from the acquisition of business of Oregano Life Private Limited. Refer Note 45 for further details.
For CGU/Group of CGU's containing goodwill at the core business level, management conducts impairment assessment and compares the carrying amount of such CGU/ Group of CGU's with its recoverable amount. Recoverable amount is value in use of the CGU/Group of CGU's computed based upon discounted cash flow projections for 5 years. The key assumptions used for computation of value in use are the growth rate and discount rate as specified below. The key assumptions have been determined based on management's calculations after considering, past experiences and other available internal information and are consistent with external sources of information to the extent applicable.
Growth rates:
Projections are based on the budgets/forecasts using a steady growth rate for subsequent years. In current scenario, terminal growth rate of 4% has been derived to offset inflation, basis past industry trend analysis.
Discount rates:
The discount rates reflect appropriate adjustments relating to market risk and specific risk factors of each segment. While calculating value in use discount rate of 13.55% has been considered.
Cash flow assumptions:
The management assumed that the business will be operated prudently and that the company shall continue to operate and that there are no unforeseen adverse changes in the economic conditions affecting the business, the market, or the industry.
Key assumptions:
Key assumptions include revenue and cost synergies over the forecast period for 5 years.
Recoverable Amount:
The recoverable amount of 'Ayurvedic Healthcare Segment' is 5 1,78,802 lakhs which is based on value in use.
Impairment:
For CGUs/Group of CGUs containing goodwill, the impairment assessment, taking into account above assumptions, did not result in any impairment loss and the management believes that any reasonably possible change in the key assumptions would not cause the carrying amount to exceed the recoverable amount of the said CGUs/Group of CGUs.
(ii) Terms and rights attached to equity shares
The Company has only one class of Equity Shares having a par value of t 2 per share. (31 March 2025 and 01 April 2024: t 10 per share). Each holder of Equity Shares is entitled to one vote per share. In the event of liquidation, the Equity shareholders are eligible to receive the remaining assets of the Company after distribution of all preferential amounts, in proportion to their shareholding.
In the year ended 31 March 2022, the Company had issued bonus shares totalling to 1,00,00,080 equity shares on 25 August 2021 (90 equity shares for every one share held) and 1,10,48,954 equity shares on 03 November 2023 (4 equity shares for every 5 share held).
On 12 June 2025, the Holding Company sub-divided/split its equity shares from one equity share of face value t 10 each, fully paid-up, into five equity shares of face value t 2 each, fully paid-up. The subdivision did not result in any change in the paid-up share capital of the Company.
The board of directors in their meeting held on 16 May 2025 has recommended a dividend of t 5.47 (before share split) of the face value of t 10 each for the FY 2024-25, t 1.10 (post share split) of face value of t 2 each was approved by the shareholders in the Annual General Meeting of the Company dated 29 September 2025. The same has been paid during the year.
The board of directors of the Company at its meeting held on 30 May 2026, has recommended a final dividend of t 4.50 per equity share to the shareholders of the Company for the year ended 31 March 2026, subject to the approval of the shareholders in the forthcoming Annual General Meeting.
35. SEGMENT REPORTING
Operating segments are reported in a manner consistent with the internal reporting provided to the Chief Operating Decision Maker ("CODM") of the Company. The CODM is considered to be the one who makes strategic decisions and is responsible for allocating resources and assessing the financial performance of the operating segments. Information reported to the CODM for the purposes of resource allocation and assessment of segment performance focuses on the types of goods delivered or services rendered.
With regard to the segment reporting, the Company has identified the following operating and reportable segments:
(a) Ayurvedic products/medicines
(b) Ayurvedic healthcare services
(c) Others
The Company has disclosed this Segment Reporting in Financial Statements as per Ind AS 108.
Note:
(i) No single external customer represents 10% or more of the Company's total revenue for the year ended 31 March 2026 and 31 March 2025.
(ii) There is no inter-segment revenue for the year ended 31 March 2026 and 31 March 2025.
(iii) There is no non current asset other than financial instruments which is located outside India.
36. LEASES
The Company has leases for buildings. With the exception of short-term leases and leases of low-value underlying assets, each lease is reflected on the balance sheet as a right-of-use asset and a lease liability. The Company classifies its right-of-use assets in a consistent manner to its property, plant and equipment.
Lease payments to be made under reasonably certain extension options are also included in the measurement of the lease liability. The lease payments are discounted using incremental borrowing rate of the Company, being the rate the Company would have to pay to borrow the funds necessary to obtain an asset of similar value to the right-of-use asset in a similar environment with similar terms, security and conditions. The average remaining lease term is 2.8 years (31 March 2025: 3.8 years).
37. SHARE BASED PAYMENT
I a. Description of share based payment arrangements- Employee Stock Option Scheme 2024
The Jeena Sikho Employee Stock Option Scheme 2024 has been adopted by the Board of Directors on 27 February 2024, read with the Special Resolution passed by the Members of the Company on 27 February 2024 and shall be deemed to come into force with effect from 27 February 2024 being the date of approval by the Members. Pursuant to this, the Company granted options to eligible employees at an exercise price of 510 per option on 28 March 2024 i,e. the grant date of the employee stock option. Each option is convertible into one Equity Share of the Company upon vesting subject to the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 and the terms and conditions of the scheme.
The maximum number of shares that may be issued pursuant to exercise of options granted to the participants under this Scheme shall not exceed 6,50,000 post split (1,30,000 pre split) shares of the Company.Subject to applicable laws, the Company reserves the right to increase or reduce such number of shares as it deems fit.
The maximum number of the shares that may be issued pursuant to the grant of the options to each grantee under ESOS 2024 shall be 100,000 (20,000 pre spilt) provided that maximum number of shares with respect to which options may be granted to a single employee shall not exceed 1% of the issued capital of the Company at any point of time.
The terms and conditions of the grant as per the plan are as under:
A. Vesting period
Vesting of the options shall take place as per the following schedule:
- 25% of options shall vest at the end of a period of 2.5 years from date of grant
- 75% of options shall vest at the end of a period of 5 years from date of grant
B. Exercise period
The exercise period shall commence from the date of vesting and shall close on the expiry of one year from the last vesting date (i.e., vesting date of the second tranche) for the respective grant of option. The employee shall have a right to exercise all the option vested in him within the exercise period.
Further, during the current financial year, the Company's equity shares were sub-divided (split) in the ratio of 1:5, whereby one equity share of face value 510 each was split into five equity shares of face value 52 each.
Consequent to the above sub-division and in accordance with the terms of the ESOP Scheme and the principles of Ind AS 102, the ESOPs outstanding were proportionately adjusted.
Accordingly, the number of stock options outstanding was increased, and exercise price per option was reduced proportionately,so as to preserve the economic value of the options granted to employees.
II a. Description of share based payment arrangements- Employee Stock Option Scheme 2025
The Jeena Sikho Employee Stock Option Scheme 2025 has been adopted by the Board of Directors on 29 September 2025, read with the Special Resolution passed by the Members of the Company on 29 September 2025 and shall be deemed to come i nto force with effect from 29 September 2025 being the date of approval by the Members. Pursuant to this, the Company granted options to eligible employees at an exercise price of 52 per option on 01 January 2026 and 25 March 2026 i,e. the grant date of the employee stock option as explained in note 37(II b). Each option is convertible into one Equity Share of the Company upon vesting subject to the Securities and Exchange Board of India (Share Based
Employee Benefits and Sweat Equity) Regulations, 2021 and the terms and conditions of the scheme.
The maximum number of shares that may be issued pursuant to exercise of options granted to the participants under this Scheme shall not exceed 2,50,000 shares of the Company. Subject to applicable laws, the Company reserves the right to increase or reduce such number of shares as it deems fit.
The maximum number of the shares that may be issued pursuant to the grant of the options to each grantee under ESOS 2025 shall be 25,000 provided that maximum number of shares with respect to which options may be granted to a single employee shall not exceed 1% of the issued capital of the Company at any point of time.
V. The underlying expected volatility was determined by reference to historical data of the Company's shares over a period of time since its floatation on the National Stock Exchange. No special features inherent to the options granted were incorporated into measurement of fair value.
38. EMPLOYEE BENEFITS
The Company has adopted Indian Accounting Standard (Ind AS) - 19 on Employee Benefits as under:
38.1 Defined contribution plans
Provident fund
In accordance with the Employee's Provident Fund and Miscellaneous Provisions Act, 1952, eligible employees of the Company are entitled to receive benefits in respect of provident fund, a defined contribution plan, in which both employees and the Company make monthly contributions at a specified percentage of the covered employees' salary. The contributions, as specified under the law, are made to the employee provident fund organization (EPFO).
The total expenses recognised in the statement of profit and loss during the year on account of defined contribution plans amounted to 5 701.24 Lakhs (31 March 2025: 5 467.62 Lakhs).
38.2 Defined obligation plans
Gratuity
The Company has an obligation towards gratuity, a defined benefit retirement plan covering eligible employees. The plan provides for a lump-sum payment to vested employees at retirement, death while in employment or on termination of employment of an amount equivalent to 26 days salary payable for each completed year of service. Vesting occurs upon completion of five years/one year (one year in case of fixed term employees) of service. The Company does not make any contributions to gratuity funds and the plan is unfunded. The Company follows Ind AS 19 'Employee Benefits' and uses Projected Unit Credit Method to value defined benefit obligations.
The defined benefit plans expose the Company to a number of actuarial risks as below:
(a) Interest risk: A decrease in the bond interest rate will increase the plan liability.
(b) Salary risk: The present value of the defined benefit plan liability is calculated by reference to the future salaries of plan participants. As such, an increase in the salary of the plan participants will increase the plan's liability.
(c) Longevity risk: The present value of the defined benefit plan liability is calculated by reference to the best estimate of the mortality of plan participants. An increase in the life expectancy of the plan participants will increase the plan's liability.
38.3 The Government of India has consolidated 29 existing labour legislations into a united framework comprising four Labour Codes viz Code on Wages, 2019, Industrial Relations Code, 2020, Code on Social Security, 2020, and Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as 'the New Labour Codes'). The New Labour Codes have been made effective from November 21, 2025. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. Basis the Company's assessment, the estimated incremental impact amounting to 5 124.86 lacs has been recognized in the standalone statement of Profit and Loss for the year ended 31 March 2026. The Company continues to monitor the finalization of Central/State rules and clarifications from the Government on other aspects of the New Labour Codes and would provide appropriate accounting effect on the basis of such developments as needed.
38.4 Other short term benefits
Compensated absences
Employee benefit expenses for the year is 33.79 lacs (31 March 2025: Nil) towards compensated absences which has been recognised in the statement of profit and loss. Provision for compensated absences as on 31 march 2026 33.79 lacs (31 March 2025: Nil).
i) Fair value hierarchy
a. Financial assets and financial liabilities measured at fair value in the balance sheet are divided into three levels of a fair value hierarchy. The three levels are defined based on the observability of significant inputs to the measurement, as follows:
Level 1: Level 1 hierarchy includes financial instruments measured using quoted prices in an active market. This includes listed equity instruments, traded debentures and mutual funds that have quoted price/declared NAV. The fair value of all equity instruments (including debentures) which are traded in the stock exchanges is valued using the closing price as at the reporting period.
Level 2: Level 2 hierarchy includes financial instruments that are not traded in an active market (for example, traded bonds/ debentures, over the counter derivatives). The fair value in this hierarchy is determined using valuation techniques which maximise the use of observable market data and rely as little as possible on entityspecific estimates. If all significant inputs required to fair value an instrument are observable, the instrument is included in level 2.
Level 3: If one or more of the significant Inputs is not based on observable market data, the instrument is included in level 3. Fair values are determined in whole or in part using a valuation model based on assumptions that are neither supported by prices from observable current market transactions in the same instrument nor are they based on available market data. Financial instruments such as unlisted equity shares, loans are included in this hierarchy.
Valuation process and technique used to determine fair value
For level 1 instruments:
The fair value of investments in mutual fund units is based on the net asset value ('NAV') as stated by the issuers of these mutual fund units in the published statements as at each reported balance sheet date. NAV represents the price at which the issuer will issue further units of mutual fund and the price at which issuers will redeem such units from the investors.
For level 2 instruments:
The Company has classified outstanding warrants within Level 2 of the fair value hierarchy, as the valuation is based on observable market inputs other than quoted prices included within Level 1. The fair value of warrants is determined using a Black-Scholes option pricing model valuation technique which incorporates observable inputs. The valuation of warrants is performed at each reporting date to reflect current market conditions, using internally developed valuation models, which are reviewed and validated by management and based on inputs that are primarily observable in the market, with limited use of judgment.
For level 3 instruments:
Investments in LLP (classified under Level 3 of fair value hierarchy) do not carry significant credit risk exposure, as these represent equity/ownership interests rather than contractual financial assets and accordingly, no expected credit loss assessment is required for such investments. Since the LLP is yet to commence operations and no material events have occurred, cost is considered a reasonable approximation of fair value.
b. Fair value of financial assets and liabilities measured at amortised cost:
The carrying amounts of trade receivables, trade payables, cash and cash equivalents, bank balances, loans, other current financials assets and liabilities are considered to be the same as their fair values, due to their short-term nature.
The management believes that the current rate of interest on the loans are in close approximation from market rates applicable to the Company. Therefore, the management estimates that the fair value of these borrowings are approximate to their respective carrying values.
iii) Financial risk management
The Company's activities expose it to market risk, liquidity risk and credit risk. The Company's board of directors has overall responsibility for the establishment and oversight of the Company's risk management framework. This note explains the sources of risk which the entity is exposed to and how the entity manages the risk and the related impact in the financial statements.
a. Credit risk
Credit risk is the risk that a counterparty fails to discharge an obligation to the Company. The Company is exposed to this risk for various financial instruments, for example by granting loans and receivables to customers, placing deposits, etc. The Company's maximum exposure to credit risk is limited to the carrying amount of following types of financial assets.
- cash and cash equivalents,
- trade receivables,
- loans and advances,
- investments,
- other bank balances, and
- other financial assets
Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company's receivables from customers, loans.
Credit risk on cash and cash equivalents is limited as the Company generally invests in deposits with banks with high credit ratings assigned by domestic credit rating agencies. While cash and cash equivalents are also subject to the impairment requirements of Ind AS 109, the identified impairment loss was immaterial.
The Company has investments in mutual funds which are measured at fair value through profit and loss (FVTPL), investments in subsidiaries measured at cost and investment in LLP for which cost is considered a reasonable approximation of fair value since the LLP is yet to commence operations and no material events have occurred. The management considers all these investments to have low credit risk.
The maximum exposure to the credit risk at the reporting date is primarily from trade receivables. Trade receivables are unsecured and are derived from revenue earned from customers primarily located in India. For these trade receivables, the Company does not presume significant increase in credit risk when financial assets are past 30 days but monitor the recoverability on case to case basis. The Company does monitor the economic environment in which it operates.
The Company considers the probability of default upon initial recognition of loan and whether there has been a significant
increase in credit risk on an ongoing basis throughout each reporting period. To assess whether there is a significant increase in credit risk, the Company compares the risk of a default occurring on the loan as at the reporting date with the risk of default as at the date of initial recognition. It considers available reasonable and supportive forwarding¬ looking information. Especially the following indicators are incorporated:
(i) actual or expected significant adverse changes in business, financial or economic conditions that are expected to cause a significant change to the borrower's ability to meet its obligations.
(ii) actual or expected significant changes in the operating results of the borrower.
Credit risk has always been managed by the Company through credit approvals, establishing credit limits and continuously monitoring the creditworthiness of customers to which the Company grants credit terms in the normal course of business. Credit risk in security deposits (other financial assets) is considered to be low as they form part of other commercial arrangements such as leases, therefore security deposit are impaired only when there is objective evidence of impairment. On account of adoption of Ind AS 109, the Company uses expected credit loss (ECL) model to assess the impairment loss or gain. The Company uses a provision matrix to compute the expected credit loss allowance for trade receivables. The provision matrix takes into account available external and internal credit risk factors such as Company's historical experience for customers.
c. Market risk - Interest rate risk
The Company's policy is to minimise interest rate cash flow risk exposures on long-term financing. At the reporting periods end, the Company is not exposed to changes in market interest as it does not have any variable interest rate borrowings. The Company's investments in fixed deposits pay fixed interest rates.
d. Market risk - Price risk
The Company's exposure to price risk arises from investments held and classified in the balance sheet at fair value through profit or loss. To manage the price risk arising from investments, the Company diversifies its portfolio of assets.
Sensitivity
For the listed equity securities, an average volatility of 10% has been observed during the year ended 31 March 2026 (31 March 2025: 10%). This volatility figure is considered to be a suitable basis for estimating how profit or loss and equity would have been affected by changes in market risk that were reasonably possible at the reporting date.
41. CAPITAL MANAGEMENT POLICIES AND PROCEDURES
The Company's objective for capital management is to maximize shareholder's value, safeguard business continuity and support the growth of the Company. The Company determines the capital requirement based on annual operating plan and other strategic investment plans. The Company aims to manage its capital efficiently so as to safeguard its ability to continue as a going concern and to optimize returns to all its shareholders. The Company's funding requirements are met through internal accruals. The Company is not subject to any externally imposed capital requirements.
43. CORPORATE SOCIAL RESPONSIBILITY
As per Section 135 of the Companies Act, 2013, a company, meeting the applicability threshold, needs to spend at least 2% of its average net profit for the immediately preceding three financial years on corporate social responsibility (CSR) activities. The areas for CSR activities are promoting health care, promoting education, rural development projects and environment sustainability. A CSR committee has been formed by the Company as per the Act. The funds were primarily utilized throughout the year on these activities which are specified in Schedule VII of the Companies Act, 2013.
d. The change is primarily attributable to increase in revenue from operations in the current year.
e. The change in ratio is primarily attributable to the significant increase in the revenue from operations during the year.
f. The change in ratio is primarily attributable to the increase in the profit and revenue during the current year in comparison to the previous year.
g. The change in ratio is primarily attributable to increase in earnings before interest and taxes in comparison to the previous year.
h. The change in ratio is primarily attributable to the increase in the actual investment against income generated from invested funds.
45. BUSINESS COMBINATION a. Summary of acquisition
On 3rd October, 2024, the Company acquired five branches consisting of Ayurvedic Therapy Centres from another Company named Oregano Life Private Limited as a going concern for a consolidated price of 5 6,915.70 lakhs.
The five branches acquired are at locations - Kishan Kunj (Delhi), Mayur Vihar (Delhi), Jothwara (Rajasthan), Alwar (Rajasthan) and Sanganer (Rajasthan).
The aforementioned acquisition is being accounted for as a business combination in accordance with Ind AS 103 — Business Combinations, whereby the identifiable assets acquired and liabilities assumed are recognised at their respective fair values as at the acquisition date. The excess of the consideration transferred over the net fair value of identifiable assets and liabilities, if any, is recognised as goodwill.
Goodwill in acquisition represents residual asset value attributable to unidentified intangible assets acquired by acquirer. It will not be deductible for tax purposes and it will be tested for impairment annually as required by IND AS 36. (Refer Note 5 to these financial statements for impairment assessment).
b. Revenue and profit contribution
The acquired business contributed revenue of 5 802.76 lakhs and profit of 5 306.61 lakhs to the Company for the year ended 31 March 2025.
If the acquisitions had taken place on 1 April 2024, standalone revenue from operations and profit for the year ended 31 March 2025 would have been 5 48,108.47 lakhs and 5 11,215.72 lakhs respectively.
46. FIRST TIME ADOPTION OF IND AS
These are the Company's first financial statements prepared in accordance with Ind AS. For the year ended 31 March 2025, the Company prepared its financial statements in accordance with accounting standards referred to in paragraph 7 of the Companies (Accounts) Rules, 2014 (Previous GAAP) notified under section 133 of the Companies Act, 2013.
The accounting policies set out in note 2 have been applied in preparing the financial statements for the year ended 31 March 2026, the comparative information presented in these financial statements for the year ended 31 March 2025 and in the preparation of opening IND AS balance sheet at 01 April 2024 (the Company's date of transition).
In preparing its IND AS balance sheet as at 01 April 2024 and in presenting the comparative information for the year ended 31 March 2025, the Company has adjusted its amounts reported previously in the financial statements prepared in accordance with previous GAAP.
Accordingly, the Company prepared first Ind AS financial statements which comply with Ind AS applicable for period ending on 31 March 2026, together with the comparative period data as at and for the year ended 31 March 2025, with a Ind AS transition date of 1 April 2024. This note explains the principal adjustments made by the Company in restating its financial statements prepared in accordance with previous GAAP and an explanation of how the transition from previous GAAP to Ind AS has affected the Company's financial position, financial performance and cash flows is set out in the following tables and notes.
A. Ind AS optional exemptions
1. Deemed cost for property, plant and equipment and intangible assets
Ind AS 101 permits a first-time adopter to elect to continue with the carrying value for all of its property, plant and equipment as recognised in the financial statements as at the date of transition to Ind AS, measured as per the Previous GAAP and use that as its deemed cost as at the date of transition after making necessary adjustments for de¬ commissioning liabilities. This exemption can also be used for intangible assets covered by Ind AS 38 Intangible Assets. Accordingly, the Company has elected to measure all of its property, plant and equipment and intangible assets at their Previous GAAP carrying value.
2. Impairment of financial assets
At the date of transition to Ind AS, determining whether there has been a significant increase in credit risk since the initial recognition of a financial instrument would require undue cost or effort, the Company has recognised a loss allowance at an amount equal to lifetime expected credit losses at each reporting date until that financial instrument is derecognised.
3. Leases
The Company has elected to measure the right of use assets at the date of transition an amount using modified retrospective approach, adjusted by the amount of any prepaid or accrued lease payments relating to that lease recognised in the Balance Sheet immediately before the date of transition to Ind AS. Further, the following expedients were used on transition to Ind AS:
- the use of a single discount rate to a portfolio of leases with reasonably similar characteristics.
- the accounting for operating leases with a remaining lease term of less than 12 months as on the transition date as short-term leases.
- the exclusion of initial direct costs for the measurement of the right of use asset at the date of initial application.
- use of hindsight, such as in determining the lease term as the contract contains the options to extend and terminate the lease.
B. Ind AS mandatory exceptions
1. Estimates
An entity's estimates in accordance with Ind ASs at the date of transition to Ind AS shall be consistent with estimates made for the same date in accordance with Previous GAAP (after adjustments to reflect any difference in accounting policies), unless there is objective evidence that those estimates were in error.
Ind AS estimates as at 1 April 2024 are consistent with the estimates as at the same date made in conformity with Previous GAAP. The Company made estimates for impairment of financial assets based on expected credit loss model in accordance with Ind AS at the date of transition as these were not required under Previous GAAP.
2. Classification and measurement of financial assets and liabilities
The classification and measurement of financial assets and financial liabilities will be made considering whether the conditions as per Ind AS 109, "Financial Instruments", are met based on facts and circumstances existing at the date of transition.
Financial assets can be measured using effective interest method by assessing its contractual cash flow characteristics only on the basis of facts and circumstances existing at the date of transition and if it is impracticable to assess the elements of modified time value of money, i.e., the use of effective interest method, fair value of financial asset at the date of transition shall be the new carrying amount of that asset. The measurement exemption applies for financial liabilities as well.
Applying a requirement is impracticable when the entity cannot apply it after making every reasonable effort to do so. It is impracticable to apply the:
(a) The effects of the retrospective application or retrospective restatement are not determinable;
(b) The retrospective application or restatement requires assumptions about what management's intent would have been in that period.
The retrospective application or retrospective restatement requires significant estimates of amounts and it is impossible to distinguish objectively information about those estimates that existed at that time.
Notes
(a) Under previous IGAAP, goodwill was amortized over the period in which the economic benefit from the acquired business is expected to flow to the Company and intangible assets were amortized based on the assesed usefule life. The Company has reassessed the useful life of goodwill and determined that it has an indefinite useful life. Goodwill and intangible assets with indefinite life are not amortized under Ind AS. Instead, goodwill is subject to an annual impairment test and the assumption of indefinite life of intangible assets reviewed annually. Accordingly the amortization charge under previous IGAAP has been adjusted.
Goodwill has been recomputed during the year based on the purchase price allocation (PPA) as per Ind AS. Under Ind AS, goodwill is determined based on purchase price allocation, which involves allocating the consideration paid to the identifiable assets and liabilities at fair value. Accordingly, goodwill has been recomputed during the transition.
(b) Provision for Gratuity is recomputed based on actuarial valuation under Ind AS, resulting in adjustment to employee benefit obligations. The acturial gain/loss have been transferred to Other Comprehensive Income (OCI) net of tax intead of profit and loss as prescribed by the IND AS.
(c) Employee stock expenses has been recorded based on the fair value of the options at grant date under Ind AS.
(d) The Company has valued its financial assets (current investment) at fair value.The impact for change in fair value as on date of transition (i.e., 01 April 2024), is recognized in opening equity and changes thereafter are recognized in the Statement of Profit and Loss or OCI based on the classification of same.
(e) Under previous IGAAP, rent payments were charged to the Statement of Profit and Loss. Under Ind AS, for long¬ term and high-value leases, a Right-of-Use (ROU) asset and corresponding lease liability are recognized. The ROU asset is amortized over the lease term, and interest on the lease liability is recorded in the Statement of Profit and Loss, replacing the earlier rent expense.
(f) Expected credit losses are recognized for all financial assets subsequent to initial recognition other than financial assets in FVTPL category.The impairment losses and reversals are recognised in Statement of Profit and Loss.
(g) The impact of transition adjustment together with Ind-AS mandate of using balance sheet approach for computation of deferred taxes has resulted in charge to the reserves, on the date of transition, with consequential impact to the Profit and Loss Account for the subsequent periods.
(h) Figures have been regrouped/re-classified of previous periods wherever necessary for better presentation and disclosures and the same are not considered material to these financial statements.
The transition from previous GAAP to Ind AS has not made a material impact on the statement of cash flows.
47. ADDITIONAL INFORMATION NOT DISCLOSED ELSEWHERE IN THE FINANCIALS STATEMENTS
(a) Borrowing secured against current assets
The Company does not have borrowings from financial institutions on the basis of security of current assets.
(b) Benami Property
The Company does not have any benami property, where any proceeding has been initiated or pending against the Company for holding any Benami property.
(c) Willful defaulter
The Company is not declared a willful defaulter by any bank or financial institution or any other lender.
(d) Relationship with struck off companies
The Company has not entered into any transactions with companies struck off under section 248 of the Companies Act, 2013 or section 560 of Companies Act, 1956.
(e) Compliance with number of layers of companies
The Company has complied with the number of layers prescribed under section 2(87) of the Companies Act, 2013 read with Companies (Restriction on number of Layers) Rules, 2017.
(f) Compliance with approved scheme(s) of arrangements
The Company has not entered into any scheme of arrangement which has an accounting impact on current or previous financial years.
(g) Registration of charges or satisfaction with Registrar of Companies
The Company does not have any charges or satisfaction which is yet to be registered with ROC beyond the statutory period.
(h) Details of funds advanced or loaned or invested in intermediaires and further invested or loaned by intermediaries:
(i) The Company has not advanced or loaned or invested funds to any other persons or entities (other than the transactions as disclosed below), including foreign entities (Intermediaries) with the understanding that the Intermediary shall:
(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company (Ultimate Beneficiaries); or
(b) provide any guarantee, security or the like to or on behalf of the Ultimate Beneficiaries.
(ii) The Company has not received any fund from any persons or entities, including foreign entities (Funding Party) with the understanding (whether recorded in writing or otherwise) that the Company shall:
(a) directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party (Ultimate Beneficiaries) or
(b) provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries
(i) Undisclosed income
The Company has not entered into any such transaction which is not recorded in the books of accounts that has been surrendered or disclosed as income during the year in the tax assessments under the Income Tax Act, 1961 (such as, search
or survey or any other relevant provisions of the Income Tax Act, 1961.
(j) Details of Crypto Currency or Virtual Currency
The Company has not traded or invested in Crypto currency or Virtual Currency during the current or previous financial years.
(k) Valuation of Property, Plant and Equipment and intangible asset
The Company has not revalued its property, plant and equipment (including right-of-use assets) or intangible assets or both during the current or previous years.
(l) The borrowings obtained by the Company from banks and financial institutions have been applied for the purposes for which such loans were taken.
48. The Ministry of Corporate Affairs (MCA) has prescribed a requirement for companies under the proviso to Rule 3(1) of the Companies (Accounts) Rules, 2014 inserted by the Companies (Accounts) Amendment Rules, 2021 requiring companies, which uses accounting software for maintaining its books of account, shall use only such accounting software which has a feature of recording audit trail of each and every transaction, creating an edit log of each change made in the books of account along with the date when such changes were made and ensuring that the audit trail cannot be disabled. The Company has used accounting software for maintaining its books of account which have a feature of recording audit trail (edit log) facility and the same has been operated throughout the year for all relevant transactions recorded in the software except for instances mentioned below:
49. The Management has assessed the subsequent events to the year end and is of the view that there no material events which require adjustment or disclosure in the standalone financial statements.
|